Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-24-000036
Filing Date
2024-10-31
Accepted
2024-10-30 19:13:33
Documents
118
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhc-20240930.htm   iXBRL 10-Q 2776937
2 EX-10.1 exhibit101q32024.htm EX-10.1 179609
3 EX-10.2 exhibit102q32024.htm EX-10.2 8863
4 EX-31.1 exhibit311q32024.htm EX-31.1 10088
5 EX-31.2 exhibit312q32024.htm EX-31.2 10135
6 EX-32.1 exhibit321q32024.htm EX-32.1 6575
7 EX-32.2 exhibit322q32024.htm EX-32.2 6508
13 GRAPHIC image_0a.jpg GRAPHIC 107987
  Complete submission text file 0000885590-24-000036.txt   13999213

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20240930.xsd EX-101.SCH 99728
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20240930_cal.xml EX-101.CAL 94441
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20240930_def.xml EX-101.DEF 566719
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20240930_lab.xml EX-101.LAB 895595
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20240930_pre.xml EX-101.PRE 747668
121 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20240930_htm.xml XML 2438108
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 241411897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)